603014 威高血净
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.6467.5868.3749.01913.497
总资产报酬率 ROA (%)1.3756.1846.5746.7539.827
投入资产回报率 ROIC (%)1.5847.2107.8978.40912.366

边际利润分析
销售毛利率 (%)38.92040.22742.29143.74042.906
营业利润率 (%)15.55915.44215.32714.91511.005
息税前利润/营业总收入 (%)15.89415.35314.97614.71010.929
净利润/营业总收入 (%)13.08312.79812.46912.5169.193

收益指标分析
经营活动净收益/利润总额(%)96.11691.51794.19894.24096.039
价值变动净收益/利润总额(%)11.8655.5606.6794.9447.199
营业外收支净额/利润总额(%)-0.582-1.070-1.230-0.574-3.060

偿债能力分析
流动比率 (X)3.7073.3022.2691.8241.485
速动比率 (X)3.0592.7201.6921.2051.083
资产负债率 (%)15.61517.30619.93323.13027.190
带息债务/全部投入资本 (%)2.4603.0474.7213.5646.415
股东权益/带息债务 (%)3,920.6763,148.9341,989.0232,658.9601,428.216
股东权益/负债合计 (%)540.410477.838401.672332.341267.780
利息保障倍数 (X)37.389207.211-91.021-122.70043.555

营运能力分析
应收账款周转天数 (天)87.66584.16587.76594.901105.568
存货周转天数 (天)133.484126.276143.425141.416121.664